{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:12:24Z","timestamp":1789193544559,"version":"build-2803163510"},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"DOI":"10.1093\/ckj\/sfag274","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T11:46:53Z","timestamp":1786535213000},"source":"Crossref","is-referenced-by-count":0,"title":["Thromboembolic risk and factor Xa inhibitor use in nephrotic syndrome: a pilot study in a predominantly Hispanic cohort"],"prefix":"10.1093","volume":"19","author":[{"given":"Palacios-Cuervo","family":"Fernando","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Texas Health Science Center at San Antonio , San Antonio, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Crestani","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Texas Health Science Center at San Antonio , San Antonio, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debnath","family":"Subrata","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Texas Health Science Center at San Antonio , San Antonio, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Lorenzo","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, University of Texas Health Science Center at San Antonio , San Antonio, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tareq","family":"Nassar","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Texas Health Science Center at San Antonio , San Antonio, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7190-6665","authenticated-orcid":false,"given":"Swetha Rani","family":"Kanduri","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Texas Health Science Center at San Antonio , San Antonio, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"2026091201515909800_bib1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/ndt\/gfw227","article-title":"Association of serum albumin level and venous thromboembolic events in a large cohort of patients with nephrotic syndrome","volume":"32","author":"Gyamlani","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"2026091201515909800_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases","volume":"100","author":"KDIGO EXECUTIVE COMMITTEE","year":"2021","journal-title":"Kidney Int"},{"key":"2026091201515909800_bib3","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.ekir.2025.01.042","article-title":"Safety and efficacy of oral direct factor Xa inhibitors in patients with nephrotic syndrome: results from a national retrospective study","volume":"10","author":"Arches","year":"2025","journal-title":"Kidney Int Rep"},{"key":"2026091201515909800_bib4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2215\/CJN.04250511","article-title":"Venous thromboembolism in patients with membranous nephropathy","volume":"7","author":"Lionaki","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026091201515909800_bib5","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.ekir.2018.02.010","article-title":"Direct-acting oral anticoagulants as prophylaxis against thromboembolism in the nephrotic syndrome","volume":"3","author":"Sexton","year":"2018","journal-title":"Kidney Int Rep"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfag274\/70619117\/sfag274.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/9\/sfag274\/70619117\/sfag274.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/9\/sfag274\/70619117\/sfag274.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:52:01Z","timestamp":1789192321000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfag274\/8759693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":5,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfag274","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,8,12]]},"article-number":"sfag274"}}